2024 ESC热点聚焦:12场热线会议,38项Hot Line研究引领学术前沿
2024-07-25 来源:医脉通
关键词: ESC 2024

8月30日-9月2日,2024年欧洲心脏病学会年会(ESC 2024)将在英国伦敦盛大召开。今年大会的主题是“个性化心血管护理(personalising cardiovascular care)”,聚焦疾病发展的各个阶段,通过个性化治疗降低风险,改善患者预后。近日,ESC官网公布了12场HOT LINE(共38项研究)和26场Late-Breaking Science(共163项研究)的具体日程。


在HOT LINE专场中,将首次介绍最近完成且未发表的新型临床试验的主要终点。让我们先睹为快吧!


640(1).jpg

(文中时间为伦敦当地时间)


HOT LINE 1

时间:8月30日,11:00-12:09

会场:London

➤HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy

3期HELIOS-B研究主要结果:Vutrisiran治疗转甲状腺素蛋白淀粉样变心肌病(ATTR-CM)患者

➤Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control

ABYSS试验结果及其对血压和心率控制的影响:既往心肌梗死患者停用β受体阻滞剂

➤STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial

STOP-or-NOT研究:一项多中心随机对照试验,评估肾素-血管紧张素系统抑制剂持续使用与停用对术后并发症的影响


HOT LINE 2

时间:8月31日,08:15-09:46

会场:London

➤The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity

BedMed和BedMed-Frail随机对照试验:降压时机对死亡率和并发症的影响

➤Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail

降压药物睡前服药试验的荟萃分析,包括来自BedMed和BedMed Frail试验的个体患者数据

➤GMRx2 - Efficacy and safety of a novel triple single pill combination

新型三药单片复方制剂GMRx2(含替米沙坦、氨氯地平和吲哒帕胺)治疗高血压的有效性和安全性

➤QUADRO - A single 4-drug combination in hypertension

QUADRO——单片四药联合治疗高血压

➤VERONICA-Nigeria - deliVERy of Optimal blood pressure coNtrol in afrICA

VERONICA-Nigeria研究:在非洲提供最佳血压控制


HOT LINE 3

时间:8月31日,11:00-12:06

会场:London

➤RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

RESHAPE-HF2研究:经皮修复症状性心力衰竭患者中重度或重度功能性二尖瓣反流

➤MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

MATTERHORN研究:在心力衰竭合并继发性二尖瓣反流患者中,经导管二尖瓣修复术和外科二尖瓣修复术的比较

➤Tri.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

TRI.FR多中心随机试验:经导管缘对缘修复术治疗严重孤立性继发性三尖瓣反流


HOT LINE 4

时间:8月31日,16:15-17:21

会场:London

➤ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery

ASSURE DES研究:非心脏手术前冠状动脉支架置入患者的围手术期抗血小板治疗

➤SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting

SWEDEGRAFT研究:“不接触”静脉移植物取材技术在冠状动脉旁路移植术(CABG)中的应用

➤The TIGHT-K trial - Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery

TIGHT-K试验:心脏手术后补钾与房颤预防


HOT LINE 5

时间:8月31日,17:35-18:41

会场:London

➤NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

NOTION-3研究:经导管主动脉瓣置入术(TAVI)患者的经皮冠状动脉介入治疗(PCI)

➤POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?

POPULAL PAUSE TAVI研究:TAVI期间继续or中断口服抗凝治疗?

➤RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis

RHEIA研究:女性重度主动脉瓣狭窄患者经导管主动脉瓣置换术和外科主动脉瓣置换术的比较


HOT LINE 6

时间:9月1日,08:15-09:41

会场:London

➤STEEER-AF - Stroke prevention and rhythm control therapy

STEEER-AF研究:卒中预防和节律控制治疗

➤OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation

OCEANIC-AF研究:Asundexian和阿哌沙班抗凝治疗在房颤患者中的比较

➤EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary arthery disease

EPIC-CAD研究:艾多沙班单药与双联抗血栓治疗房颤合并稳定型冠状动脉疾病的比较


HOT LINE 7

时间:9月1日,11:00-12:06

会场:London

➤FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction

FINEARTS-HF研究:非奈利酮治疗射血分数轻度降低和保留的心力衰竭

➤MRAs in heart failure - An individual patient data meta-analysis of randomised trials

心力衰竭中的盐皮质激素受体拮抗剂(MRAs):随机试验的个体患者数据荟萃分析

➤FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials

FINE-HEART研究:非奈利酮在心力衰竭和慢性肾脏病试验中的参与者水平汇总分析


HOT LINE 8

时间:9月1日,16:15-17:21

会场:London

➤SENIOR RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial

SENIOR RITA研究:老年非ST段抬高型心肌梗死(NSTEMI)患者随机介入治疗试验

➤EARTH-STEMI - Complete vs. culprit-only revascularization in older STEMI patients

EARTH-STEMI研究:老年ST段抬高型心肌梗死(STEMI)患者完全血运重建和仅罪犯血管血运重建的比较

➤SCOFF - Fasting or no fasting before cardiac catherisation procedures

SCOFF研究——心脏导管术前禁食和不禁食的比较


HOT LINE 9

时间:9月1日,17:35-18:36

会场:London

➤STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-olds

STROKESTOP II研究:在75岁人群中,随机系统性NT-proBNP和心电图筛查房颤

➤GUARD-AF - ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals

GUARD-AF研究:在老年人中通过筛查未确诊的房颤来减少卒中

➤MIRACLE-AF - A Novel Model of IntegRAted Care of OLdEr Patients with Atrial Fibrillation in rural China

MIRACLE-AF研究:中国农村老年房颤患者的综合管理新模式


HOT LINE 10

时间:9月2日,11:00-12:06

会场:London

➤SHAM-PVI - A randomised sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

SHAM-PVI研究——症状性房颤肺静脉隔离的随机假手术对照研究

➤SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation

SUPPRESS-AF研究:低电压区域消融治疗持续性房颤患者房性快速性心律失常复发的疗效

➤CRABL-HF - Cryoballoon vs. Radiofrequency Ablation of AF in Patients with Heart Failure

CRABL-HF研究:冷冻球囊消融与射频消融治疗心力衰竭患者房颤的比较


HOT LINE 11

时间:9月2日,13:45-14:45

会场:London

➤OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions

OCCUPI研究:光学相干断层扫描(OCT)引导下复杂病变患者的冠状动脉介入治疗

➤INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

INFINITY-SWEDEHEART研究1年主要结果:Bioadaptor(DynamX生物适配器)与当代药物洗脱支架PCI的比较

➤REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions: a multicenter, non-inferiority trial

REC-CAGEFREE I多中心、非劣效性试验:药物涂层球囊血管成形术+补救支架置入 vs. 择期支架置入术治疗冠脉De Novo病变


HOT LINE 12

时间:9月2日,15:15-16:21

会场:London

➤PROTEUS - A prospective randomised controlled trial evaluating the use of artificial intelligence in stress echocardiography

PROTEUS前瞻性随机对照试验:评估人工智能在负荷超声心动图中的应用

➤RAPIDxAI - Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting evidence to practice using artificial intelligence

RAPIDxAI研究:利用人工智能加快证据到实践,重新设计急诊科疑似心源性胸痛评估的临床方法

➤WESTCOR-POC - Point of care versus centralised high-sensitivity cardiac troponin in the emergency department

WETCOR-POC研究:急诊科高敏肌钙蛋白的床旁检测vs.集中式检测


8月30日-9月2日,医脉通邀您一同感受大洋彼岸、地球彼端的学术脉搏!


相关阅读
#2024 ESC热点聚焦:4部新指南、12场热线会议引领学术前沿


(本网站所有内容,凡注明来源为“医脉通”,版权均归医脉通所有,未经授权,任何媒体、网站或个人不得转载,否则将追究法律责任,授权转载时须注明“来源:医脉通”。本网注明来源为其他媒体的内容为转载,转载仅作观点分享,版权归原作者所有,如有侵犯版权,请及时联系我们。)

1
收藏 分享